AI assistant
Sending…
IRIDEX CORP — Director's Dealing 2011
Oct 12, 2011
34978_dirs_2011-10-12_fd5d0157-b2f7-457e-a09f-47d2af09810c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRIDEX CORP (IRIX)
CIK: 0001006045
Period of Report: 2011-10-10
Reporting Person: Beck Dominik (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-10-10 | Common Stock | A | 75000 | — | Acquired | 75000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-10-10 | Stock Option Right to Buy | $3.40 | A | 135000 | Acquired | 2018-10-10 | Common Stock (135000) | Direct |
Footnotes
F1: Shares are represented by restricted stock units and will vest annually with 24,999 shares vesting after one year and the remaining 50,001 shares vesting in equal installments of 16,667 shares each over the remaining three year period.
F2: This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3.
F3: The shares shall vest as follows: 12/48ths of the shares shall vest 12 months after the Vesting Commencement Date and 1/48th of the shares shall vest each month thereafter.
More from IRIDEX CORP
Interim / Quarterly Report
2026
May 19
Regulatory Filings
2026
May 19
Annual Report
2026
Apr 24
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 12
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Jan 29
Director's Dealing
2026
Jan 28